Thynk Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Iviva Medicalivivamedical.comMar 2018
IVIVA Medical develops fully implantable bioartificial kidneys as a potential cure for patients with chronic kidney disease, diabetes, and kidney failure.
BiotechHealthtechMedical DevicesBeverly, US
Harald C Ott(Director)Brock Reeve(Executive Officer)
PartnerJim Plante· solo GP
Co-investorsBold Capital PartnersPrime Movers Lab
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.